EMA Application withdrawn: Cokiera — AbbVie Ltd

View source ↗

Summary

EMA has withdrawn the application for Cokiera by AbbVie Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Hepatitis

Drugs mentioned

• Cokiera

Snippet

Status: Application withdrawn. Therapeutic area: Hepatitis C, Chronic. MAH: AbbVie Ltd. Decision date: 16/09/2016